| scholarly article | Q13442814 |
| P50 | author | E. Albert Reece | Q111990913 |
| Zhiyong Zhao | Q52350046 | ||
| P2860 | cites work | Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes | Q77893164 |
| Prenatal diagnosis of alobar holoprosencephaly at 10 weeks of gestation | Q77916806 | ||
| Studies in human reproduction. III. The frequency of congenital malformations in the offspring of nondiabetic and diabetic individuals | Q78387339 | ||
| Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos | Q79224843 | ||
| Neural tube defects | Q79867086 | ||
| Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats | Q80168435 | ||
| Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy | Q80193517 | ||
| Demonstration of the essential role of protein kinase C isoforms in hyperglycemia-induced embryonic malformations | Q81322503 | ||
| Diabetes and pregnancy | Q81798267 | ||
| Management of diabetes in pregnancy | Q82797509 | ||
| Folic acid and safflower oil supplementation interacts and protects embryos from maternal diabetes-induced damage | Q83016159 | ||
| Diagnosis and classification of diabetes mellitus | Q22255452 | ||
| Nitric oxide synthases in mammals | Q24528695 | ||
| Nitric oxide and peroxynitrite in health and disease | Q24645400 | ||
| Development of the heart: (2) Septation of the atriums and ventricles | Q24674138 | ||
| Development of the heart: (1) formation of the cardiac chambers and arterial trunks | Q24674182 | ||
| Formation of the middle ear: recent progress on the developmental and molecular mechanisms | Q28203422 | ||
| Protein quality control, retention, and degradation at the endoplasmic reticulum | Q28252854 | ||
| Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy | Q28284049 | ||
| Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats | Q28565775 | ||
| N-Acetylcysteine and alpha-cyano-4-hydroxycinnamic acid alter protein kinase C (PKC)-delta and PKC-zeta and diminish dysmorphogenesis in rat embryos cultured with high glucose in vitro | Q28577060 | ||
| Spatial and temporal patterns of ERK signaling during mouse embryogenesis | Q28594004 | ||
| Cytosolic phospholipase A2 | Q28609569 | ||
| A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. | Q29035699 | ||
| The BCL-2 protein family: opposing activities that mediate cell death | Q29547380 | ||
| Peroxynitrite: biochemistry, pathophysiology and development of therapeutics | Q29615424 | ||
| Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis | Q29615808 | ||
| Apoptosis: controlled demolition at the cellular level | Q29620114 | ||
| Sonographic prenatal diagnosis of central nervous system abnormalities | Q30816888 | ||
| Two-dimensional ultrasound is accurate in the diagnosis of fetal craniofacial malformation | Q31068105 | ||
| Modulation of PGE2 generation in the diabetic embryo: effect of nitric oxide and superoxide dismutase | Q32123753 | ||
| Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review | Q33274272 | ||
| Treatment of acetaminophen overdose | Q33672312 | ||
| International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy | Q33683832 | ||
| Reduction in embryonic malformations and alleviation of endoplasmic reticulum stress by nitric oxide synthase inhibition in diabetic embryopathy. | Q33714217 | ||
| Caspase-8: a key role in the pathogenesis of diabetic embryopathy. | Q33726220 | ||
| Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects | Q33750553 | ||
| Protein folding in the ER. | Q33794209 | ||
| Oculoauriculovertebral abnormalities in children of diabetic mothers | Q33858617 | ||
| Gestational diabetes and its impact on the neonate. | Q33960472 | ||
| Management of diabetes mellitus complicating pregnancy | Q33973107 | ||
| Congenital facial palsy and ipsilateral deafness: Association with maternal diabetes mellitus | Q50598907 | ||
| Skeletal malformations in rat offspring. Long-term effect of maternal insulin-induced hypoglycemia during organogenesis. | Q50801299 | ||
| Endoplasmic reticulum stress in maternal diabetes-induced cardiac malformations during critical cardiogenesis period. | Q51412981 | ||
| Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. | Q52178231 | ||
| Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. | Q52188403 | ||
| Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. | Q52193997 | ||
| Diabetes mellitus affects prostaglandin E2 levels in mouse embryos during neurulation. | Q52200415 | ||
| Glutathione status in diabetes-induced embryopathies. | Q52203709 | ||
| Function of COX-2 and prostaglandins in neurological disease | Q36954203 | ||
| Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats | Q36975500 | ||
| The endoplasmic reticulum and the unfolded protein response | Q37006310 | ||
| Endoplasmic reticulum stress responses | Q37014237 | ||
| Type 2 diabetes mellitus: prevention of macrovascular complications. | Q37104865 | ||
| Expansion and evolution of cell death programmes | Q37139298 | ||
| Why have antioxidants failed in clinical trials? | Q37161580 | ||
| Glycosylated haemoglobin: measurement and clinical use. | Q37184010 | ||
| Vitamins and cardiovascular disease | Q37282850 | ||
| Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence | Q37302298 | ||
| Diabetes and apoptosis: neural crest cells and neural tube. | Q37351323 | ||
| Sonoembryology and early prenatal diagnosis of neural anomalies | Q37385904 | ||
| Global standardisation of HbA1c. | Q37416591 | ||
| Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications | Q37418305 | ||
| Prenatal screening and diagnosis of neural tube defects | Q37419235 | ||
| Inhibition of inducible nitric oxide synthase in respiratory diseases | Q37554654 | ||
| Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart | Q37556067 | ||
| Endoplasmic reticulum stress in beta-cells and development of diabetes | Q37576455 | ||
| The oxidative stress menace to coronary vasculature: any place for antioxidants? | Q37597236 | ||
| Nuchal translucency and fetal cardiac malformations | Q37679767 | ||
| The fetal and maternal consequences of gestational diabetes mellitus | Q37685098 | ||
| Phospholipases, enzymes that share a substrate class | Q37802189 | ||
| Biology of Endoplasmic Reticulum Stress in the Heart | Q37808904 | ||
| Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. | Q37826384 | ||
| Diabetes in pregnancy: health risks and management | Q37849080 | ||
| Pregestational diabetes | Q37908040 | ||
| Ultrasound of fetal cardiac anomalies | Q37937287 | ||
| Diabetes-induced birth defects: what do we know? What can we do? | Q37968210 | ||
| Phospholipases in biology and medicine | Q38005402 | ||
| Alpha-fetoprotein and the prenatal diagnosis of neural tube defects | Q39464059 | ||
| Development of the middle and external ear in man | Q39715272 | ||
| Diabetes in pregnancy 1985. | Q39730138 | ||
| Chapter 4. Prenatal Diagnosis of Open Neural Tube Defects | Q40104649 | ||
| Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts). | Q40144414 | ||
| The syndrome of caudal dysplasia: a review, including etiologic considerations and evidence of heterogeneity | Q40197770 | ||
| The infant of the diabetic mother: today and tomorrow | Q40303090 | ||
| Protein kinase C: cellular target of the second messenger arachidonic acid? | Q40546806 | ||
| Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats | Q40894024 | ||
| Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis | Q40925859 | ||
| Diabetes complications: why is glucose potentially toxic? | Q40978355 | ||
| Protein kinase C isozymes and the regulation of diverse cell responses | Q34012841 | ||
| Cyclooxygenases: structural and functional insights | Q34014369 | ||
| The nuchal translucency and the fetal heart: a literature review | Q34017264 | ||
| Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation | Q34023352 | ||
| Pathogenesis of diabetes-induced congenital malformations | Q34091873 | ||
| Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care | Q34095380 | ||
| Nitric oxide synthase: models and mechanisms | Q34096471 | ||
| Molecular aspects of lipoic acid in the prevention of diabetes complications | Q34099645 | ||
| Neural patterning in the vertebrate embryo | Q34114837 | ||
| The isoprostanes: their quantification as an index of oxidant stress status in vivo | Q34119174 | ||
| Implications of inducible nitric oxide synthase expression and enzyme activity | Q34169024 | ||
| Neurogenesis in the vertebrate neural tube | Q34187403 | ||
| Prevention of fetal malformation with antioxidants in diabetic pregnancy | Q34268964 | ||
| Screening for neural tube defects | Q34333062 | ||
| Diabetes complicating pregnancy | Q34341189 | ||
| New technologies for the management of pregestational diabetes mellitus. | Q34383522 | ||
| Nitric oxide: one of the more conserved and widespread signaling molecules | Q34386520 | ||
| Mitochondria, oxygen free radicals, and apoptosis | Q34386750 | ||
| Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. | Q34466568 | ||
| Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. | Q34551280 | ||
| Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning | Q34567884 | ||
| Diabetic embryopathy: pathogenesis, prenatal diagnosis and prevention | Q34657501 | ||
| Protein kinase Cβ2 inhibition reduces hyperglycemia-induced neural tube defects through suppression of a caspase 8-triggered apoptotic pathway | Q34673067 | ||
| Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes | Q34737010 | ||
| Diabetes mellitus and birth defects | Q34803469 | ||
| Redox control of cell death | Q34820717 | ||
| Gestational diabetes: the need for a common ground | Q34982756 | ||
| Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting | Q34989325 | ||
| Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. | Q35022230 | ||
| Congenital malformations in offspring of diabetic mothers--animal and human studies | Q35078485 | ||
| The offspring of gestational diabetes | Q35093319 | ||
| Mitochondrial Production of Oxygen Radical Species and the Role of Coenzyme Q as an Antioxidant | Q35112579 | ||
| Physiological and pathological roles of Apaf1 and the apoptosome. | Q35136123 | ||
| SOD1 overexpression in vivo blocks hyperglycemia-induced specific PKC isoforms: substrate activation and consequent lipid peroxidation in diabetic embryopathy | Q35177954 | ||
| The true face of JNK activation in apoptosis | Q35185558 | ||
| Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks | Q35201256 | ||
| Phospholipase A2 and signal transduction | Q35362338 | ||
| Cranial neural crest and the building of the vertebrate head | Q35549127 | ||
| Cardiovascular malformations in infants of diabetic mothers | Q35581713 | ||
| A decade of caspases | Q35591686 | ||
| The Bcl-2 family: roles in cell survival and oncogenesis. | Q35591695 | ||
| Regulation of the expression of inducible nitric oxide synthase. | Q35605774 | ||
| Significance of the cranial neural crest. | Q35618164 | ||
| The essential role of protein kinase Cδ in diabetes-induced neural tube defects | Q35684260 | ||
| Mitogen-activated protein kinases in apoptosis regulation | Q35743118 | ||
| Free radicals in cell biology | Q35893762 | ||
| Cell biology of cardiac cushion development. | Q36083465 | ||
| Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy | Q36084769 | ||
| Embryology of neural tube development | Q36087221 | ||
| The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy | Q36107472 | ||
| Cardiac neural crest | Q36212774 | ||
| Diabetic embryopathy: studies using a rat embryo culture system and an animal model | Q36244546 | ||
| Life in the balance: how BH3-only proteins induce apoptosis. | Q36294226 | ||
| Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions | Q36330216 | ||
| Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development | Q36330450 | ||
| Recent advances in craniofacial morphogenesis | Q36471176 | ||
| Management of diabetes from preconception to the postnatal period: summary of NICE guidance | Q36511925 | ||
| c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal causation in diabetic embryopathy | Q36560617 | ||
| Vitamin E in humans: an explanation of clinical trial failure | Q36604517 | ||
| How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? | Q36625791 | ||
| Neural crest contribution to the cardiovascular system | Q36640214 | ||
| Caspase function in programmed cell death | Q36643566 | ||
| ER stress and diseases. | Q36731474 | ||
| Endoplasmic reticulum stress. | Q36812724 | ||
| Endoplasmic reticulum stress in disease pathogenesis | Q36842308 | ||
| Endoplasmic reticulum stress: signaling the unfolded protein response | Q36844431 | ||
| Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and th | Q36921787 | ||
| PGE2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos | Q41102028 | ||
| Epithelial-mesenchymal transformations in early avian heart development | Q41242280 | ||
| The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes | Q41250366 | ||
| A potential mechanism of DL-beta-hydroxybutyrate-induced malformations in mouse embryos | Q41384409 | ||
| Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. | Q41927698 | ||
| Embryopathy in experimental diabetic gestation: assessment of PGE2 level, gene expression of cyclooxygenases and apoptosis | Q42162937 | ||
| Cardiac malformations and alteration of TGFbeta signaling system in diabetic embryopathy | Q43176001 | ||
| Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity | Q43587199 | ||
| In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes | Q43620468 | ||
| Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium | Q43643772 | ||
| Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants | Q43906606 | ||
| Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. | Q43953703 | ||
| 8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro | Q44157479 | ||
| Aberrant patterns of cellular communication in diabetes-induced embryopathy. I. Membrane signalling | Q44176240 | ||
| Effects of ergothioneine on diabetic embryopathy in pregnant rats | Q44207509 | ||
| Maternal diabetes mellitus and infant malformations | Q44210817 | ||
| Pregnancy planning in women with pregestational diabetes | Q44236944 | ||
| Predictive value of early pregnancy glycohemoglobin in the insulin-treated diabetic patient | Q44311091 | ||
| Maternal Diabetes In Vivo and High Glucose In Vitro Diminish GAPDH Activity in Rat Embryos | Q44418732 | ||
| Prevention of Congenital Malformations in Infants of Insulin-dependent Diabetic Mothers | Q44472047 | ||
| Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring | Q44493904 | ||
| Major malformations in infants of IDDM women. Vasculopathy and early first-trimester poor glycemic control | Q44574655 | ||
| Preconception care of diabetes. Glycemic control prevents congenital anomalies | Q45034798 | ||
| Rate and type of congenital anomalies among offspring of diabetic women | Q45131075 | ||
| Holoprosencephaly in human embryos: Epidemiologic studies of 150 cases | Q45159232 | ||
| Apoptosis and its pathway in early post-implantation embryos of diabetic rats | Q45223223 | ||
| Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro | Q45242130 | ||
| World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. | Q46016413 | ||
| The prognostic value of hemoglobin A1c in predicting fetal heart disease in diabetic pregnancies. | Q46023109 | ||
| Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach | Q46065397 | ||
| Prevention of neural tube defects by loss of function of inducible nitric oxide synthase in fetuses of a mouse model of streptozotocin-induced diabetes | Q46090104 | ||
| Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice | Q46340414 | ||
| Neonatal morbidities in gestational diabetes mellitus | Q46357778 | ||
| Assessment and management of pregnancies complicated by pregestational and gestational diabetes mellitus. | Q46365000 | ||
| Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women | Q46372863 | ||
| Folic acid prevents congenital malformations in the offspring of diabetic mice | Q46379217 | ||
| High malformation rates and decreased mortality in infants of diabetic mothers managed after the first trimester of pregnancy (1956-1978). | Q46380732 | ||
| Diabetes and pregnancy. A 21-year Swedish material. | Q46381204 | ||
| Malformations in infants of diabetic mothers | Q46382791 | ||
| CONGENITAL SPINAL ANOMALIES IN INFANTS OF DIABETIC MOTHERS | Q46398858 | ||
| Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. | Q46520798 | ||
| A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid | Q46549814 | ||
| Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis | Q46786796 | ||
| Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro. | Q46821281 | ||
| Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy | Q46827589 | ||
| The incidence of neural tube defects in the fetus and neonate of the insulin-dependent diabetic woman | Q46915628 | ||
| Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. | Q46928208 | ||
| Major congenital anomalies in infants and glycosylated hemoglobin levels in insulin-requiring diabetic mothers | Q46961337 | ||
| Pregestational Diabetes Mellitus and Pregnancy | Q47866207 | ||
| Why don't women with diabetes plan their pregnancies? | Q48008352 | ||
| Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos | Q48427734 | ||
| Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats | Q48553119 | ||
| Abundant expression of GLUT1 and GLUT3 in rat embryo during the early organogenesis period. | Q52208965 | ||
| Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. | Q52242652 | ||
| Morphological and physiological effects of beta-hydroxybutyrate on rat embryos grown in vitro at different stages. | Q52245184 | ||
| Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. | Q52537166 | ||
| Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in the organogenesis stage mouse embryo. | Q52572774 | ||
| Congenital heart disease in infants of diabetic mothers. | Q53761872 | ||
| Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. | Q53835969 | ||
| Prenatal diagnosis of craniofacial malformations with ultrasonography | Q61845966 | ||
| Congenital malformations in infants of diabetic mothers | Q67486618 | ||
| Maternal diabetes: the risk for specific birth defects | Q67554672 | ||
| D-(-)-beta-hydroxybutyrate-induced effects on mouse embryos in vitro | Q68524578 | ||
| Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus | Q68755584 | ||
| Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden | Q68759907 | ||
| Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations | Q69528800 | ||
| First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy | Q69621592 | ||
| The Effect of Intensified Conventional Insulin Therapy before and during Pregnancy on the Malformation Rate in Offspring of Diabetic Mothers | Q70353790 | ||
| Syndrome of phocomelic diabetic embryopathy (caudal dysplasia) | Q70373732 | ||
| Fatty acid content of yolk sac and embryo in hyperglycemia-induced embryopathy and effect of arachidonic acid supplementation | Q70415870 | ||
| The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program | Q70558612 | ||
| Fetal growth delay and maternal hemoglobin A1c in early diabetic pregnancy | Q70570864 | ||
| Premaxillary protrusion: a sonographic clue to bilateral cleft lip and palate | Q70771555 | ||
| The development of the atrioventricular junction in the human heart | Q71006297 | ||
| Insulin-dependent diabetes mellitus | Q71046915 | ||
| Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos | Q71552435 | ||
| Screening for neural tube defects | Q71627932 | ||
| Holoprosencephaly in infants of diabetic mothers | Q71690242 | ||
| Dietary polyunsaturated fatty acid prevents malformations in offspring of diabetic rats | Q71714342 | ||
| Effects of maternal diabetes on early embryogenesis. Alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate | Q71763747 | ||
| Gestational diabetes | Q71876649 | ||
| Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis | Q71939415 | ||
| Glucose metabolism, triglyceride and glycogen levels, as well as eicosanoid production in isolated uterine strips and in embryos in a rat model of non-insulin-dependent diabetes mellitus during pregnancy | Q72026560 | ||
| Altered mitochondrial morphology of rat embryos in diabetic pregnancy | Q72141151 | ||
| Diabetes and pregnancy. Factors associated with seeking pre-conception care | Q72188646 | ||
| Alpha-fetoprotein screening in pregnancy-a test whose time has come | Q72677974 | ||
| Histological findings in a case of alobar holoprosencephaly diagnosed at 10 weeks of pregnancy | Q73084058 | ||
| Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats | Q73170934 | ||
| Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant | Q73285114 | ||
| Oxidative damage in pregnant diabetic rats and their embryos | Q73308690 | ||
| Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes | Q73551492 | ||
| Programmed cell death in the developing heart: regulation by BMP4 and FGF2 | Q73681185 | ||
| Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment | Q73704565 | ||
| Diminished PGE2 content, enhanced PGE2 release and defects in 3H-PGE2 transport in embryos from overtly diabetic rats | Q73750268 | ||
| Dietary myo-inositol therapy in hyperglycemia-induced embryopathy | Q74486498 | ||
| Holoprosencephaly | Q74631249 | ||
| Association between maternal diabetes mellitus and newborn oral cleft | Q77206283 | ||
| Increased prostaglandin E generation and enhanced nitric oxide synthase activity in the non-insulin-dependent diabetic embryo during organogenesis | Q77508591 | ||
| P433 | issue | 2 | |
| P921 | main subject | diabetic embryopathy | Q1335193 |
| P304 | page(s) | 207-233 | |
| P577 | publication date | 2013-04-19 | |
| P1433 | published in | Clinics in laboratory medicine | Q26841969 |
| P1476 | title | New concepts in diabetic embryopathy | |
| P478 | volume | 33 |
| Q30313201 | Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts |
| Q36591397 | Amelioration of intracellular stress and reduction of neural tube defects in embryos of diabetic mice by phytochemical quercetin |
| Q35922833 | Efficacy of Spirulina platensis in improvement of the reproductive performance and easing teratogenicity in hyperglycemic albino mice |
| Q92803717 | Fetal hypoxia and hyperglycemia in the formation of phenytoin-induced cleft lip and maxillary hypoplasia |
| Q43100860 | Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects |
| Q36588276 | Identification of novel cell survival regulation in diabetic embryopathy via phospholipidomic profiling. |
| Q41321787 | Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy |
| Q67463425 | Inflammatory Consequences of Maternal Diabetes on the Offspring Brain: a Hippocampal Organotypic Culture Study. |
| Q51076120 | Maternal diabetes modulates offspring cell proliferation and apoptosis during odontogenesis via the TLR4/NF-κB signalling pathway. |
| Q90697209 | Maternal hyperglycemia and fetal cardiac development: Clinical impact and underlying mechanisms |
| Q35278924 | MicroRNA biomarkers for early detection of embryonic malformations in pregnancy |
| Q54979626 | Modulation of nuclear factor-κB signaling and reduction of neural tube defects by quercetin-3-glucoside in embryos of diabetic mice. |
| Q41441147 | Reevaluation of Antioxidative Strategies for Birth Defect Prevention in Diabetic Pregnancies. |
| Q101241312 | Sudden cardiac death in children with congenital heart disease: a critical review of the literature |
| Q89684787 | The biology of ergothioneine, an antioxidant nutraceutical |
Search more.